Cargando…
Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A bayesian network meta-analysis
Background: In light of clinical trials comparing different doses of tirzepatide with selective glucagon-like peptide-1 receptor agonist (GLP1-RA) or insulin analogue, a bayesian network meta-analysis was conducted to investigate the efficacy and safety of tirzepatide in patients with type 2 diabete...
Autores principales: | Guan, Ruifang, Yang, Qing, Yang, Xiaolei, Du, Wandi, Li, Xuening, Ma, Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613929/ https://www.ncbi.nlm.nih.gov/pubmed/36313305 http://dx.doi.org/10.3389/fphar.2022.998816 |
Ejemplares similares
-
Efficacy and safety of tirzepatide in patients with type 2 diabetes: A systematic review and meta-analysis
por: Tang, Yan, et al.
Publicado: (2022) -
Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis
por: Li, Jiyifan, et al.
Publicado: (2023) -
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
por: Sinha, Rachel, et al.
Publicado: (2023) -
Comparing Efficacy and Safety of Different Doses of Tirzepatide for the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
por: Khan, Zarghuna, et al.
Publicado: (2023) -
Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats
por: Guo, Xiying, et al.
Publicado: (2023)